Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
One of the largest radiopharma companies in the world is acquiring global rights to a pair of novel therapeutic and diagnostic drugs used to target a peptide receptor overexpressed in prostate and breast cancers.
"This article will serve as a landmark reference for navigating short-term labor challenges in radiology," explains one editorial about the suggestions.
AI can safely and accurately identify healthy breast tissue on ultrafast breast MRI, negating the need for a radiologist’s closer look and, in the process, lowering cancer screening costs and widening patient access to breast MRI.
Researchers have developed a novel cardiovascular MRI protocol as an option to the invasive gold standard, endomyocardial biopsy, for monitoring heart-transplant patients at risk of suffering organ rejection.
A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.
The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.
Iodinated contrast is most widely used in patients undergoing CT studies for, in descending order, abdominopelvic, chest, head/neck and brain indications.
Computer-aided detection boosted by AI has often proven superior to traditional CAD over the past decade, yet the “new way” has been slow to win broad adoption.
Prior to the final proposal’s release, the American College of Radiology reached out to CMS to offer its recommendations on payment rates for five out of the six the new codes.